Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry A Jacobson

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
Journal of Clinical Lipidology|September 17, 2022
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid AssociationBruce A Warden, John R Guyton, Adrienne C Kovacs, et al.
Journal of the American College of Cardiology|September 23, 2017
Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin MyopathyBeth A Taylor, Robert J Sanchez, Terry A Jacobson, et al.
The American Journal of Cardiology|April 4, 2006
Statin safety: an assessment using an administrative claims databaseMark J Cziraky, Vincent J Willey, James M McKenney, et al.
Journal of Clinical Lipidology|January 9, 2021
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reductionCarl E Orringer, Michael J Blaha, Ron Blankstein, et al.
Journal of the American Geriatrics Society|April 10, 2025
Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and the American Geriatrics SocietyVera Bittner, Sunny A Linnebur, Dave L Dixon, et al.
Journal of Clinical Lipidology|April 25, 2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, et al.
Journal of Clinical Lipidology|April 18, 2025
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics SocietyVera Bittner, Sunny A Linnebur, Dave L Dixon, et al.
American Journal of Preventive Cardiology|January 30, 2026
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMMichael Miller, Deepak L Bhatt, Eliot A Brinton, et al.
Journal of the American College of Cardiology|August 24, 2019
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride TertilesDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smokingMichael Miller, Deepak L Bhatt, Ph Gabriel Steg, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
Journal of Clinical Lipidology|September 17, 2022
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid AssociationBruce A Warden, John R Guyton, Adrienne C Kovacs, et al.
Journal of the American College of Cardiology|September 23, 2017
Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin MyopathyBeth A Taylor, Robert J Sanchez, Terry A Jacobson, et al.
The American Journal of Cardiology|April 4, 2006
Statin safety: an assessment using an administrative claims databaseMark J Cziraky, Vincent J Willey, James M McKenney, et al.
Journal of Clinical Lipidology|January 9, 2021
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reductionCarl E Orringer, Michael J Blaha, Ron Blankstein, et al.
Journal of the American Geriatrics Society|April 10, 2025
Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and the American Geriatrics SocietyVera Bittner, Sunny A Linnebur, Dave L Dixon, et al.
Journal of Clinical Lipidology|April 25, 2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, et al.
Journal of Clinical Lipidology|April 18, 2025
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics SocietyVera Bittner, Sunny A Linnebur, Dave L Dixon, et al.
American Journal of Preventive Cardiology|January 30, 2026
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMMichael Miller, Deepak L Bhatt, Eliot A Brinton, et al.
Journal of the American College of Cardiology|August 24, 2019
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride TertilesDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smokingMichael Miller, Deepak L Bhatt, Ph Gabriel Steg, et al.
Pageof 19